359 related articles for article (PubMed ID: 32034077)
41. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
42. ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma.
Ojha R; Leli NM; Onorati A; Piao S; Verginadis II; Tameire F; Rebecca VW; Chude CI; Murugan S; Fennelly C; Noguera-Ortega E; Chu CT; Liu S; Xu X; Krepler C; Xiao M; Xu W; Wei Z; Frederick DT; Boland G; Mitchell TC; Karakousis GC; Schuchter LM; Flaherty KT; Zhang G; Herlyn M; Koumenis C; Amaravadi RK
Cancer Discov; 2019 Mar; 9(3):396-415. PubMed ID: 30563872
[TBL] [Abstract][Full Text] [Related]
43. Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Liu J; Rebecca VW; Kossenkov AV; Connelly T; Liu Q; Gutierrez A; Xiao M; Li L; Zhang G; Samarkina A; Zayasbazan D; Zhang J; Cheng C; Wei Z; Alicea GM; Fukunaga-Kalabis M; Krepler C; Aza-Blanc P; Yang CC; Delvadia B; Tong C; Huang Y; Delvadia M; Morias AS; Sproesser K; Brafford P; Wang JX; Beqiri M; Somasundaram R; Vultur A; Hristova DM; Wu LW; Lu Y; Mills GB; Xu W; Karakousis GC; Xu X; Schuchter LM; Mitchell TC; Amaravadi RK; Kwong LN; Frederick DT; Boland GM; Salvino JM; Speicher DW; Flaherty KT; Ronai ZA; Herlyn M
Cancer Res; 2021 Oct; 81(20):5230-5241. PubMed ID: 34462276
[TBL] [Abstract][Full Text] [Related]
44. A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis.
Grillo E; Corsini M; Ravelli C; di Somma M; Zammataro L; Monti E; Presta M; Mitola S
Cancer Lett; 2021 Jan; 496():84-92. PubMed ID: 33035615
[TBL] [Abstract][Full Text] [Related]
45. Acly promotes metabolic reprogramming and induction of IRF4 during early CD8
Vaughn N; Haviland DL
Cytometry A; 2021 Aug; 99(8):825-831. PubMed ID: 33325591
[TBL] [Abstract][Full Text] [Related]
46. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
[TBL] [Abstract][Full Text] [Related]
47. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
48. BRAF
Lunavat TR; Cheng L; Einarsdottir BO; Olofsson Bagge R; Veppil Muralidharan S; Sharples RA; Lässer C; Gho YS; Hill AF; Nilsson JA; Lötvall J
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5930-E5939. PubMed ID: 28684402
[TBL] [Abstract][Full Text] [Related]
49. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
50. The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα.
Smith MP; Sanchez-Laorden B; O'Brien K; Brunton H; Ferguson J; Young H; Dhomen N; Flaherty KT; Frederick DT; Cooper ZA; Wargo JA; Marais R; Wellbrock C
Cancer Discov; 2014 Oct; 4(10):1214-1229. PubMed ID: 25256614
[TBL] [Abstract][Full Text] [Related]
51. The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.
Gu L; Zhu Y; Lin X; Lu B; Zhou X; Zhou F; Zhao Q; Prochownik EV; Li Y
Hepatology; 2021 Jan; 73(1):160-174. PubMed ID: 32221968
[TBL] [Abstract][Full Text] [Related]
52. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.
Zhang C; Liu J; Huang G; Zhao Y; Yue X; Wu H; Li J; Zhu J; Shen Z; Haffty BG; Hu W; Feng Z
Genes Dev; 2016 Sep; 30(17):1956-70. PubMed ID: 27664236
[TBL] [Abstract][Full Text] [Related]
53. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury.
Li R; Meng M; Chen Y; Pan T; Li Y; Deng Y; Zhang R; Tian R; Xu W; Zheng X; Gong F; Liu J; Tang H; Ding X; Tang Y; Annane D; Chen E; Qu H; Li L
Cell Death Dis; 2023 Jul; 14(7):401. PubMed ID: 37414769
[TBL] [Abstract][Full Text] [Related]
54. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
Phung B; Cieśla M; Sanna A; Guzzi N; Beneventi G; Cao Thi Ngoc P; Lauss M; Cabrita R; Cordero E; Bosch A; Rosengren F; Häkkinen J; Griewank K; Paschen A; Harbst K; Olsson H; Ingvar C; Carneiro A; Tsao H; Schadendorf D; Pietras K; Bellodi C; Jönsson G
Cell Rep; 2019 Jun; 27(12):3573-3586.e7. PubMed ID: 31216476
[TBL] [Abstract][Full Text] [Related]
55. 53BP1-ACLY-SLBP-coordinated activation of replication-dependent histone biogenesis maintains genomic integrity.
Wu T; Jun S; Choi EJ; Sun J; Yang EB; Lee HS; Kim SY; Fahmi NA; Jiang Q; Zhang W; Yong J; Lee JH; You HJ
Nucleic Acids Res; 2022 Feb; 50(3):1465-1483. PubMed ID: 35037047
[TBL] [Abstract][Full Text] [Related]
56. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
Front Immunol; 2018; 9():2858. PubMed ID: 30568658
[TBL] [Abstract][Full Text] [Related]
57. Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M; Krayem M; Najem A; Sales F; Miller W; Del Rincon S; Awada A; Ghanem GE; Journe F
Mol Cancer Res; 2021 Jul; 19(7):1221-1233. PubMed ID: 33741716
[TBL] [Abstract][Full Text] [Related]
58. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
59. ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis.
Convertini P; Santarsiero A; Todisco S; Gilio M; Palazzo D; Pappalardo I; Iacobazzi D; Frontuto M; Infantino V
J Transl Med; 2023 Aug; 21(1):568. PubMed ID: 37620891
[TBL] [Abstract][Full Text] [Related]
60. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
